Our findings can contribute to a better understanding of the role of BRCA1 promoter hypermethylation in breast tumorigenesis, with potential clinical implications for the diagnosis, prognosis, and treatment of breast cancer. This evidence concerns the gene BRCA1 and breast carcinoma.